Patents by Inventor Zackery Dentmon

Zackery Dentmon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Abelson Non-Tyrosine Kinase Compounds for the Treatment of Neurodegenerative Diseases
    Publication number: 20220177480
    Abstract: The present disclosure relates to compounds for the use of treating neurodegenerative diseases and, in particular, to compounds targeting the Abelson non-tyrosine kinase (c-Abl) protein for such treatment. The neurological disorders and conditions include Parkinson's disease, Alzheimer's disease and the like. It also relates to pharmaceutical compositions and methods of treatment of such neurological disorders involving the c-Abl protein kinase.
    Type: Application
    Filed: April 17, 2020
    Publication date: June 9, 2022
    Inventors: Thomas Kaiser, Zackery Dentmon, Christopher Dalloul, Dennis Liotta
  • Phosphotidylinositol 3-kinase inhibitors
    Patent number: 10947225
    Abstract: This disclosure relates to phosphoinositide 3-kinases (PI3Ks) inhibitors such as N-(5-(imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)sulfonamide derivatives and uses related thereto. In certain embodiments, the disclosure relates to methods of treating PI3K associated diseases or conditions comprising administering an effective amount of a compound disclosed herein to a subject in need thereof. In certain embodiments, the subject is at risk of, exhibiting symptoms of, suffering from, or diagnosed with cancer or a hematological malignancy.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: March 16, 2021
    Assignee: Emory University
    Inventors: Qi Shi, Thomas Kaiser, John DiRaddo, James Snyder, Dennis Liotta, Zackery Dentmon
  • Phosphotidylinositol 3-Kinase Inhibitors
    Publication number: 20190202826
    Abstract: This disclosure relates to phosphoinositide 3-kinases (PI3Ks) inhibitors such as N-(5-(imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)sulfonamide derivatives and uses related thereto. In certain embodiments, the disclosure relates to methods of treating PI3K associated diseases or conditions comprising administering an effective amount of a compound disclosed herein to a subject in need thereof. In certain embodiments, the subject is at risk of, exhibiting symptoms of, suffering from, or diagnosed with cancer or a hematological malignancy.
    Type: Application
    Filed: May 11, 2017
    Publication date: July 4, 2019
    Inventors: Qi Shi, Thomas Kaiser, John DiRaddo, James Snyder, Dennis Liotta, Zackery Dentmon